Here are your 2 Elite stocks for the day. These are our top growth/momentum picks we are watching at the moment.

If you have any questions, please contact me at [email protected].

Be sure to check out out our recent list of our Top 5 Stocks For October 2025.

Featuring stocks such as HOOD, APP, and more.

1 Year Chart:

Buy Level:

Looking to accumulate in the $151 range. This chart is looking nearly perfect for a breakout to new highs. Stop loss would be around $140.

Category: Growth

Market Cap: $53B

Company Info:

Datadog Inc. (NASDAQ: DDOG) is a cloud-native observability and security platform that helps developers and IT teams monitor, troubleshoot, and secure applications across modern infrastructure. Its platform integrates metrics, logs, traces, user experience data, and threat detection into a single, real-time dashboard.

Why it’s a buy:

The stock is a buy in 2025 because Datadog is a mission-critical platform for the AI and cloud era, enabling organizations to maintain uptime, performance, and security as their systems grow more complex. With enterprises adopting multi-cloud and microservices architectures, the need for unified observability has never been greater—and Datadog leads the pack with a highly scalable, sticky solution.

The company continues to expand its product suite and customer base, delivering strong net revenue retention and best-in-class margins. As AI workloads put even more strain on infrastructure, Datadog’s end-to-end visibility becomes a must-have. With powerful network effects, rapid product innovation, and increasing share of wallet, Datadog is building the default operating system for modern DevOps and cloud security—making it a long-term winner in enterprise software.

Revenue:

1 Year Chart:

Buy Level:

Looking to accumulate in the $55 range. There is plenty support in the $50’s, I see this hitting new highs by the end of the month, or at least entering the $60 range if trends continue. Stop loss would be around $50.

Category: Growth

Market Cap: $12B

Company Info:

Hims & Hers Health Inc. (NYSE: HIMS) is a direct-to-consumer digital health company offering telehealth consultations, personalized treatment plans, and subscription-based wellness products. The platform covers categories like hair loss, mental health, sexual wellness, skincare, and weight loss—delivered discreetly and conveniently through its online platform.

Why it’s a buy:

The stock is a buy in 2025 because Hims is building a modern healthcare brand for the digital-first generation, with a business model that combines recurring revenue, vertical integration, and lifestyle-driven branding. The company continues to post strong revenue growth and improving margins, while expanding into high-demand verticals like GLP-1 weight loss medications and dermatology.

Hims has carved out a unique space by delivering care with accessibility, affordability, and privacy—attracting a younger, loyal customer base that’s underserved by traditional healthcare. As digital health adoption accelerates and Hims scales its product ecosystem, it stands out as a category-defining player in consumer wellness, with meaningful upside as it moves closer to profitability and brand ubiquity.

Revenue:

If you haven’t already, check out our Elite watchlist updated every week:

This is also available in the elite discord.

The #1 Trading Software in the world: Tradingview

As always you are more then welcome to send me an email at [email protected] or DM me on instagram @crowntradingllc if you have any questions about the market or stock opportunities.

If you would like to see specific statistics about the companies in these newsletters reach out to me with your suggestions!

Thank you for reading!

Jordan K.

Disclaimer: The stocks mentioned in this email do not represent the exact positions of Crown Trading, but rather ideas and opportunities we are currently monitoring. Just because a stock is featured here does not mean we own or are actively trading it. The buy levels are not recommendations. This is not financial advice, and neither myself nor Crown Trading is recommending that you buy or sell any securities. All information is for educational purposes only and should not be relied upon for investment decisions. Please do your own research before making any trades.